Maynard Um
-
-
-
-
-
-
-
Cingulate submits FDA application for ADHD drug CTx-1301
-
-
-
-
-
-
-
Cingulate Inc (CING) Reports Safety Results from Final Phase 3 Trials for CTx-1301
-
-
-
404,886 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

